Stimvia, a pioneering medical technology company specializing in neuromodulation for chronic disease treatment, has successfully completed its pilot study focused on Parkinson's Disease (PD) and is expecting promising results.
Premise Health, the leading direct health care provider for employers and unions, is expanding its behavioral health care model by adding psychiatric support to its collaborative care teams, a first of its kind approach within the direct health care industry.
WACKER has acquired the manufacturing assets and know-how of U.S.-based Bio Med Sciences Inc. to expand its expertise and business in silicone-coated healthcare products.
Hypertension, or high blood pressure, affects one in three Europeans over the age of 30 and more than one billion people worldwide. Hypertension is known as the "silent killer" because many people do not know they have it and, over time, it can lead to serious health issues.
Family Features Stroke can happen to anyone – it happens to more than 800,000 people every year in the United States. Knowing the signs of stroke and how to prevent it can help protect you or your loved ones from disabilities caused by stroke.
Kolmar BNH a manufacturer of HemoHIM, a health-enhancing functional food, has emerged as a frontrunner in the global Original Development Manufacturing (ODM) market, owing to its pioneering investments in research and development.
Medit a leading provider of dental 3D scanners and digital dentistry solutions, introduces the Medit i900 intraoral scanner, setting a new standard for speed, accuracy, and comfort.
Olympus, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, will highlight a diverse urology portfolio that can help physicians treat bladder cancer, urinary stones and enlarged prostate during this year's American Urological Association (AUA) annual meeting May 3-6 in San Antonio.
GE HealthCare (Nasdaq: GEHC) today announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its Portrait VSM vital signs monitor that can provide clinicians with an accurate view of patient vital signs to support timely clinical decisions.
Bruker is enhancing its innovative diagnostic solutions in microbial identification, antimicrobial susceptibility testing (AST), early sepsis diagnostics, and other infectious disease assays. Simplifying microbiology and infectious disease diagnostics and workflows in the clinical laboratory is a key goal for Bruker in support of earlier and improved patient treatment decisions.